Peptides DB
Research-centric peptide and protocol reference hub
Study 12 of 13Humanin literatureExperimental physiology · Animal study · Preclinical2026

Humanin ameliorates diabetes-induced testicular damage in a streptozotocin-induced mouse model.

Humanin treatment improved oxidative stress markers and testicular tissue health in a diabetic mouse model, but further studies are needed to confirm these effects in humans.

Read at Experimental physiologyAdd to compare

Where it sits

this study against the rest of the humanin corpus
4
Preclinical · this one
8
Observational
0
Open-label
0
Randomised
1
Reviews

Summary and findings

This study investigated the effects of humanin on oxidative stress parameters and histopathological alterations in testicular tissue in a streptozotocin-induced diabetic mouse model. A total of 40 adult male Balb/C mice were used, with humanin administered at a dose of 4 mg/kg for 15 days following diabetes induction. The study found significant changes in oxidative stress markers and histopathological improvements in testicular tissues following treatment.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
P < 0.05 for TAS and GSH levels in seminal vesicle fluid.Preclinical2026

Abstract

The authors’ words, as Experimental physiology supplied them

Diabetes mellitus is a major metabolic disorder closely associated with oxidative stress and male reproductive dysfunction. Humanin, a mitochondria-derived peptide, has been reported to exert cytoprotective, anti-apoptotic and antioxidant effects in various disease models; however, its role in diabetes-induced testicular damage remains unclear. This study aimed to investigate the effects of humanin on oxidative stress parameters in seminal vesicle fluid and histopathological alterations in testicular tissue in a streptozotocin (STZ)-induced diabetic mouse model. A total of 40 adult male Balb/C mice were randomly assigned into four groups: Control, Humanin (HN), STZ, and STZ+HN (n = 10 per group). Diabetes was induced via intraperitoneal administration of STZ (150 mg/kg). Humanin (4 mg/kg) was administered intraperitoneally for 15 days following diabetes induction. Total antioxidant status (TAS), total oxidant status (TOS), and glutathione (GSH) levels in seminal vesicle fluid were measured using ELISA. Testicular tissues were evaluated histopathologically and histomorphometrically. STZ-induced diabetes resulted in a significant decrease in TAS and GSH levels and an increase in TOS levels in seminal vesicle fluid (P < 0.05). Humanin treatment significantly increased TAS and GSH levels while reducing TOS levels compared to the STZ group (P < 0.05). Histopathological analysis demonstrated seminiferous tubule degeneration, germ cell loss, interstitial oedema, and vascular congestion in diabetic mice, whereas these alterations and associated histomorphometric abnormalities were significantly ameliorated following humanin treatment. Humanin attenuated diabetes-induced oxidative imbalance and testicular histopathological damage in STZ-induced diabetic mice. These findings suggest that humanin may exert protective effects against diabetes-associated testicular injury. Further studies are required to elucidate the underlying molecular mechanisms and validate these findings in broader experimental settings.

Background

The paper addresses the impact of diabetes on testicular health, which is a recognized concern in diabetic patients. Prior research has indicated that diabetes can lead to reproductive complications, but the role of Humanin in this context had not been extensively studied. This research is significant as it explores a potential protective mechanism against diabetes-induced reproductive damage.

Methods

The study utilized a streptozotocin-induced mouse model to simulate diabetes. The specific number of mice (n) used, the dosage of Humanin administered, and the duration of treatment were not reported in the abstract. Primary and secondary outcome measures were also not specified.

Results

Not reported in abstract.

Interpretation

Without specific results, it is challenging to compare these findings to existing literature or to assess the clinical significance of the observed effects. The lack of detailed statistical data limits the ability to draw firm conclusions about the efficacy of Humanin in this model. Any implications for practice remain speculative until more robust data are available.

Key findings

  • Not reported in abstract.

Limitations

  • rodent model, may not translate to humans
  • specific numeric outcomes not reported
  • lack of detailed statistical analysis

Elsewhere in the Humanin corpus

CMitochondrial-derived peptide Humanin protects granulosa cells under oxidative conditions.Reproduction (Cambridge, England) · 2023 · n=30 · HN significantly decreased H2O2-induced granulosa cell apoptosis in KGN cells, p<0.01.AnimalCRepeated Humanin Treatment Attenuates Oxidative Stress, Inflammation, and Apoptosis in Diabetic Cardiac Tissue.Biology · 2026 · Not reported in abstract.AnimalCHumanin peptide ameliorates reproductive dysfunction and restores neuroendocrine mechanisms in SSRI-treated male rats.Reproductive biology · 2026 · Not reported in abstract.AnimalCS14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis.European journal of pharmacology · 2026 · n=20 · UACR reduced by 49.5% (from 103.91 ± 7.68 to 52.50 ± 4.02 μg/mg, P < 0.001)AnimalCHumanin improved the rotenone-induced reactive oxygen species formation in PC12 cells by modulating the SIRT3/Nrf2/HO-1 signaling pathway.Toxicology and industrial health · 2026 · HN pretreatment significantly increased PC12 cell survival, p<0.001.In vitroBSerum mtDNA DAMP abundance, fragmentation and heteroplasmic variants associate with Acute Respiratory Failure outcome: A secondary analysis of study NCT00976833biorxiv-preprint · 2025 · Mean NUMT-depleted mtDNA insert size was lower in non-survivors.Human